phosphorus has been researched along with vitamin d 2 in 223 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (vitamin d 2) | Trials (vitamin d 2) | Recent Studies (post-2010) (vitamin d 2) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 3,239 | 311 | 737 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 126 (56.50) | 18.7374 |
| 1990's | 17 (7.62) | 18.2507 |
| 2000's | 41 (18.39) | 29.6817 |
| 2010's | 38 (17.04) | 24.3611 |
| 2020's | 1 (0.45) | 2.80 |
| Authors | Studies |
|---|---|
| Chutkan, W; Miller, CG | 1 |
| DeLuca, HF | 3 |
| Evans, IM; Larkins, RG; Macintyre, I | 1 |
| Arnaud, SB; Gilkinson, JB; Goldsmith, RS; Matthusen, M | 1 |
| Albertini, A; Andreoli, A; Cecchettin, M; Zamboni, G; Zoppi, G | 1 |
| Horst, RL; Littledike, ET | 2 |
| Attie, M; Brown, EM; DeLuca, HF; Downs, RW; Gardner, DG; Hamstra, AJ; Marx, SJ; Spiegel, AM | 1 |
| Christensen, MS; Lund, B; Melsen, F; Mosekilde, L; Sorenson, OH | 1 |
| Jacob, E; Lim, P; Pwee, HS; Tock, EP | 1 |
| Houston, IB; Postlethwaite, RJ | 1 |
| Absood, S; Connor, TB; Davis, C; Martin, L; Merchant, C; Norris, AH; Posner, DB; Russell, RM; Williams, JB | 1 |
| Baccari, V; Bianchi, A; Casey, H; Firenzuoli, AM; Treves, C; Zanobini, A | 1 |
| Bove, KE; Buchino, JJ; Chan, GM; Mehlhorn, D; Steichen, JJ; Tsang, RC | 1 |
| Belon, C; Dumas, R; Huguet, R; Jean, R | 1 |
| Englert, W; Schlich, D | 1 |
| Raman, T; Sharma, NL; Singh, RK; Teotia, M; Teotia, SP | 1 |
| Anaise, J; Arcan, M; Gedalia, I; Rosen, D; Simkin, A | 1 |
| Drezner, MK; Haussler, M; Lebovitz, HE; McPherson, HT; Neelon, FA | 1 |
| Adeniyi, A; Laditan, AA | 1 |
| Leissa, H; Schennetten, F | 1 |
| Connors, MH; Irias, JJ; Sheikholislam, BM | 1 |
| Fries, W; Rümenapf, G; Schwille, PO | 1 |
| Ciupagea, A; Lungu, GR; Miloş, A; Vasiu, F; Zosin, I | 1 |
| Balsan, S; Tieder, M | 1 |
| Akiel, A; Al Shawaf, T; Al-Meshari, AA; el Idrissy, AT; Moghraby, SA; Sedrani, SH | 1 |
| Kobayashi, T; Kodama, S; Matsuo, T; Okano, T; Takeuchi, A; Tasaka, Y; Tsugawa, N | 1 |
| Kutafina, EK; Naumova, VI; Panchenko, EL; Rusnak, FI; Vereskova, SA | 1 |
| Heubi, JE; Hollis, BW; Specker, B; Tsang, RC | 1 |
| Greer, FR; Marshall, S | 1 |
| Eil, C; Liberman, UA; Marx, SJ | 1 |
| Hollis, BW; Horn, J; Koo, WW; Steichen, JJ; Steiner, P; Tsang, RC | 1 |
| Cancela, L; Denne, MA; Gruson, M; Miravet, L | 1 |
| Balsan, S; Czernichow, P; Farriaux, JP; Garabedian, M; Pomarede, R; Tau, C | 1 |
| Aarskog, D; Aksnes, L; Hesse, V; Jahreis, G; Markestad, T; Plenert, W; Siebenhuner, M | 1 |
| Kosolapova, NI; Krugliakova, RP; Mitrofanova, AV; Radchenko, LG; Strukov, VI | 1 |
| Fröhling, PT; Kokot, F; Lindenau, K; Schmicker, R; Vetter, K | 1 |
| Favus, MJ; Friedman, HZ; Langman, CB | 1 |
| Greer, FR; Laskarzewski, P; Noguchi, A; Steichen, JJ; Tsang, RC; Venkataraman, PS | 1 |
| Aloia, J; Yeh, JK; Zaino, EC | 1 |
| Hillman, LS; McAlister, WH; Salmons, SJ; Slatopolsky, E | 1 |
| Charles, P; Jensen, FT; Mosekilde, L | 1 |
| Eriksen, EF; Melsen, F; Mosekilde, L | 1 |
| Sjödén, G | 1 |
| Rich, C; Rosenstreich, SJ; Volwiler, W | 1 |
| Chalmers, TM; Davie, MW; Hunter, JO; Kodicek, E; Pelc, B; Szaz, KF | 1 |
| Gupta, MM; Round, JM; Stamp, TC | 1 |
| Joly, JB | 1 |
| Bosmann, HB; Chen, PS | 4 |
| Garcia, FG; Hegsted, DM; Hunt, RD | 1 |
| Balogh, K; Kunin, AS | 1 |
| Cohanim, M; DeLuca, HF; Yendt, ER | 1 |
| Brickman, AS; Norman, AW | 1 |
| Bouillon, R; Krempien, B; Verberckmoes, R | 1 |
| Rowan, AJ; Swash, M | 1 |
| Bilyk, I; Czabanova, V; Komárková, A; Záhor, Z | 1 |
| Fujita, T; Oata, M; Okano, K; Orimo, H; Yoshikawa, M | 1 |
| Baker, RK; Burnett, V; Wallach, S | 1 |
| Davidson, DC; Dunnigan, MG; Ford, JA; Fyfe, WM; McIntosh, WB | 1 |
| Hirano, K; Ishibashi, A; Yoshino, Y | 1 |
| Buring, K; Hulth, AG; Nilsson, BE; Westlin, NE; Wiklund, PE | 1 |
| Addrizzo, JR; Baker, RK; Shai, F; Wallach, S | 1 |
| Oke, OL | 1 |
| Doughman, DJ; Hajny, RG; Nolan, S; Olson, GA | 1 |
| Russell, RI | 1 |
| Baltzer, BV; Hendricks, DG; Hoefer, JA; Luecke, RW; Miller, ER; Struthers, RD; Ullrey, DE | 1 |
| Golikov, KK | 1 |
| Cohen, RD; Vince, FP | 1 |
| Bronner, F; Hurwitz, S; Stacey, RE | 1 |
| Hendricks, DG; Hoefer, JA; Luecke, RW; Miller, ER; Ullrey, DE | 1 |
| Gogoberidze, TG | 1 |
| Bilas, LM | 1 |
| Chang, IH; Gifford, ED; Harrill, I | 1 |
| Hennequet, A; Marandian, H; Marie, J; Momenzadeh, A | 1 |
| Kaye, M | 1 |
| Stacey, TE; Stamp, TC | 1 |
| Dent, CE; Richens, A; Rowe, DJ; Stamp, TC | 1 |
| Harrand, RB; Hartles, RL | 1 |
| Ray, RD; Sevastikoglou, J | 1 |
| Ray, RD; Sevastikoglu, JA | 1 |
| Ray, RD; Sevastikoglou, JA | 1 |
| Arnaud, C; Glorieux, F; Scriver, C | 1 |
| Maher, JF; Nolph, KD; Stoltz, M | 1 |
| Just, G; Kaye, M; Wilson, M | 1 |
| Fenwick, JC; Flik, G; Smith, J; Smith, K | 1 |
| Larkins, RG | 1 |
| Bonjour, JP; Eisman, JA; Fleisch, H; Taylor, CM; Trechsel, U | 1 |
| Aarskog, D; Aksnes, L; Markestad, T | 1 |
| Adler, M; Broadus, AE; Byers, CM; Segre, GV; Stewart, AF | 1 |
| Goff, JP; Horst, RL; Littledike, ET | 1 |
| Gogel, E; Halloran, BP; Strewler, GJ | 1 |
| Aarskog, D; Aksnes, L; Halvorsen, KS; Halvorsen, S; Markestad, T | 1 |
| Bell, NH; Shaw, S; Turner, RT | 1 |
| Bell, NH; Dowdeswell, I; Epstein, S; Stern, PH; Turner, RT | 1 |
| Aarskog, D; Aksnes, L; Finne, PH; Markestad, T | 1 |
| Armbrecht, HJ; Forte, LR; Halloran, BP | 1 |
| Hiejima, T; Ikehara, C; Ishida, M; Ishii, T; Matsuda, S; Morimoto, S; Onishi, T; Seino, Y; Shimotsuji, T; Tanaka, Y; Yabuuchi, H; Yamaoka, K | 1 |
| Drezner, MK; Harrelson, JM; Lyles, KW | 1 |
| Adams, ND; Findling, JW; Gray, RW; Lemann, J; Thomas, CJ; Tyrrell, JB | 1 |
| Harrington, DD | 1 |
| Fujita, T; Furukawa, Y; Morii, H; Okano, K | 1 |
| Unakami, H | 1 |
| Berry, JL; Klimiuk, PS; Mawer, EB; Stephens, WP; Taylor, JL; Warrington, S | 1 |
| Lissner, D; Mason, RS; Posen, S; Rohl, PG | 1 |
| Chan, GM; Hollis, J; Ronald, N; Slater, P; Thomas, MR | 1 |
| Brooke, OG; Livesey, A; McIntosh, N | 1 |
| Brandli, D; Carlton, E; Goldenhersh, M; Goodman, WG; Hahn, T; Murray, C; Salusky, IB; Sanchez, CP | 1 |
| Goto, M; Hayashi, M; Seyama, Y; Yamashita, S | 1 |
| Clemens, TL; Kelsey, JL; Lindsay, R; O'Dowd, KJ | 1 |
| Hayashi, M; Horiuch, M; Kanke, Y; Seyama, Y | 1 |
| Ayala, M; Cassinelli, H; Mautalen, C; Oliveri, B | 1 |
| Brown, AJ; Denda, M; Dusso, AS; Finch, JL; Slatopolsky, E; Takahashi, F | 1 |
| Gagnemo-Persson, R; Hâkanson, R; Persson, P; Samuelsson, A | 1 |
| Chesney, RW; Coburn, JW; Frazao, JM | 1 |
| Finch, J; Ritter, C; Slatopolsky, E; Takahashi, F | 1 |
| Arruda, J; Delmez, J; Goldblat, MV; Keshav, G; Lau, A; Lindberg, JS; Llach, F; Sadler, R; Slatopolsky, E | 1 |
| Abboud, H; Gellens, ME; González, EA; Hamm, LL; Lindberg, J; Martin, KJ | 1 |
| Hayashi, M; Seyama, Y; Takegami, H; Usami, E | 1 |
| Brown, AJ; Finch, JL; Slatopolsky, E | 1 |
| Ashok, A; Chennaiah, S; Raghuramulu, N; Rao, DS | 1 |
| Acchiardo, SR; Bishop, CW; Bower, JD; Chesney, RW; Coburn, JW; Douglass, LL; Elangovan, L; Frazão, JM; Gentile, D; Goodman, WG; Kelley, BJ; Kyllo, DM; Levine, BS; Maung, HM; Mazess, RB; Norris, KC; Robertson, JA; Rodriguez, HJ | 1 |
| Erben, RG; Goldberg, M; Stangassinger, M; Weber, K | 1 |
| Acchiardo, SR; González, EA; Lindberg, J; Martin, KJ; Soltanek, C; Valdin, JR | 1 |
| Llach, F; Yudd, M | 1 |
| Abraham, M; Batlle, D; Lerma, E; McCormmick, D; Sprague, SM | 1 |
| González, EA; Martin, KJ | 1 |
| Brown, AJ; Slatopolsky, E | 1 |
| Chmielewski, C; Foerster, D | 1 |
| Alberti, D; Arzoomanian, R; Bailey, H; Bhattacharya, A; Bishop, C; Bruskewitz, R; Horvath, D; Liu, G; Marnocha, R; Mazess, R; Oettel, K; Ripple, G; Staab, MJ; Wilding, G | 1 |
| Cozzolino, M; Finch, JL; Slatopolsky, E | 1 |
| Brookshire, MA; Moe, SM; Russell, R; Zekonis, M | 1 |
| Ahya, SN; Coyne, DW; Giles, K; Grieff, M; Norwood, K; Slatopolsky, E | 1 |
| Arruda, JA; Barton Pai, A; Lau, AH; Lin, S | 1 |
| Lazarus, JM; Lowrie, E; Ofsthun, N; Teng, M; Thadhani, R; Wolf, M | 1 |
| CLAASSEN, V; WOSTMANN, BS | 1 |
| CARUGATI, L; SCALFI, U | 1 |
| GREGO, M; NORDIO, S | 1 |
| CHEN, PS; TEREPKA, AR | 1 |
| DI ROSA, M; DONATELLI, L; SORRENTINO, L | 1 |
| BARTTER, FC; BELL, NH; GERARD, ES | 1 |
| ANSALDI, N; BALOCCO, A; TREBBI, I | 1 |
| FERNBACH, J; GLAUBER, A; SILLAR, P | 1 |
| BARTTER, FC; BELL, NH; GILL, JR | 1 |
| CLARK, I; SMITH, MR | 1 |
| Baltzer, BV; Hoefer, JA; Luecke, RW; Miller, ER; Schmidt, DA; Ullrey, DE; Vincent, BH; Zutaut, CL | 1 |
| GIZA, T; HANICKA, M; HORNIK, N; JELONEK, A; REMBIESOWA, H | 1 |
| CHALLINOR, SW; POWER, DM; TONGE, RJ | 1 |
| GOLDBLOOM, RB; ROY, CC; SCRIVER, CR | 1 |
| Hoefer, JA; Luecke, RW; Miller, ER; Ullrey, DE; Zutaut, CL | 1 |
| Hoefer, JA; Luecke, RL; Miller, ER; Ullrey, DE; Zutaut, CL | 1 |
| FRETHEIM, B; GARDBORG, O | 1 |
| Colussi, G | 1 |
| Kida, Y | 1 |
| Bishop, CW; Coburn, JW; Elangovan, L; Germain, MJ; Lindberg, JS; Maung, HM; Sprague, SM; Williams, ME | 1 |
| Camargo, CA; Hernán, MA; Lazarus, JM; Ofsthun, MN; Teng, M; Thadhani, R; Wolf, M | 1 |
| Cheng, SC; Coyne, DW; Staniforth, ME | 1 |
| DeLuca, HF; Rohde, CM | 1 |
| Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F | 1 |
| Delanaye, P; Krzesinski, JM; Van Overmeire, L | 1 |
| Hall, MC; Lovato, J; Patton, S; Schwartz, GG; Stindt, D; Torti, FM | 1 |
| Abboud, H; Anger, M; Batlle, D; Coyne, D; Hippensteel, R; Kavanaugh, A; Lunde, N; Melnick, JZ; Palaparthy, RV; Pradhan, RS; Qiu, P; Smolenski, O; Williams, LA | 1 |
| Ahya, SN; Coyne, DW; Giles, K; Joist, HE; Norwood, K; Slatopolsky, E | 1 |
| Drüeke, TB; Landais, P | 1 |
| Budoff, MJ; Kalantar-Zadeh, K; Kilpatrick, RD; Kopple, JD; Kovesdy, CP; Kuwae, N; McAllister, CJ; Regidor, DL; Salusky, IB; Shinaberger, CS | 1 |
| Bedrick, EJ; Hunt, WC; Johnson, HK; Meyer, KB; Rohrscheib, MR; Stidley, CA; Tentori, F; Zager, PG | 1 |
| Boedigheimer, M; Damore, M; Fitzpatrick, D; Haas, K; Henley, C; Kiaei, P; Lacey, DL; Manoukian, R; Martin, D; McNinch, J; Shalhoub, V; Shatzen, E; Twomey, B; Ward, S | 1 |
| Cardús, A; Fernandez, E; Panizo, S; Parisi, E; Valdivielso, JM | 1 |
| Amdahl, M; Benador, N; Goldstein, SL; Greenbaum, LA; Mattingly, S; Melnick, JZ; Paredes, A; Salusky, IB; Williams, LA | 1 |
| Honkanen, TT; Kööbi, P; Mustonen, JT; Niemelä, OJ; Pörsti, IH; Rantala, IS; Repo, JM; Ruskoaho, HJ; Rysä, JM; Tahvanainen, AM; Tikkanen, I | 1 |
| Kroeger, PE; Ma, J; Nakane, M; Ruan, X; Wu-Wong, JR | 1 |
| Abboud, H; Hamm, LL; Hippensteel, R; Melnick, JZ; Pradhan, RS; Ross, EA; Sprague, SM; Tian, J; Williams, LA | 1 |
| Aguilera-Tejero, E; Guerrero, F; Lopez, I; Martin, D; Mendoza, FJ; Perez, J; Rodriguez, M | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP | 1 |
| Chaudhary, LR; Geurs, T; Hruska, KA; Lund, RJ; Mathew, S | 1 |
| Bolin, A; Dixon, D; Koch, K; Ma, J; Nakane, M; Noonan, W; Reinhart, G | 1 |
| David, K; Kumar, N; Lindberg, J; Menoyo, J; Morris, J | 1 |
| Brandenburg, V; Cozzolino, M | 1 |
| Ali, N; Chittineni, H; Durie, N; Dutka, P; Fishbane, S; Packman, M | 1 |
| Amdahl, M; Andress, DL; Heaney, RP; Lund, RJ; Williams, LA | 1 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
| Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
| Aires, I; Amaral, T; Borges, M; Cortez, J; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Matias, PJ | 1 |
| Chailurkit, LO; Chalapipat, O; Disthabanchong, S; Kurathong, S; Praditpornsilpa, K; Stitchantrakul, W; Trakarnvanich, T | 1 |
| Chow, EC; Groothuis, GM; Jin, C; Pang, KS; Sondervan, M | 1 |
| Fourtounas, C | 1 |
| Christensson, A; Fernström, A; Giæver, J; Granroth, B; Hylander, B; Jacobson, SH; Jensen, G; Weiss, L; Wikström, B; Wrege, U | 1 |
| Bernardo, M; Duggal, A; Engstrand, S; Gonzalez, AR; Hariachar, S; Hertel, J; Hunter, J; Kant, KS; Plone, M | 1 |
| Bacevicius, E; Brandi, L; Danielsen, H; Hansen, D; Kreiner, S; Lauridsen, TG; Madsen, JK; Marckmann, P; Meyer-Hofmann, H; Nielsen, JE; Rasmussen, K; Thye-Roenn, P; Tougaard, BG | 1 |
| Awni, WM; Garimella, TS; Klein, CE; Lichtenberger, O; Noertersheuser, PA; Palaparthy, R; Pradhan, RS; Williams, LA | 1 |
| Aguilera-Tejero, E; Guerrero, F; López, I; Montes de Oca, A; Rodríguez, M; Zafra, R | 1 |
| Cerezo Morales, S; Hervás Sánchez, JG; Polo Moyano, A; Prados Garrido, MD | 1 |
| Beato-Coo, L; Blanco-García, R; Bravo-López, JJ; Cossio-Annibar, C; Moreiras-Plaza, M; Nájera-de la Garza, W; Rodríguez-Goyanes, G | 1 |
| Chen, YW; Nakane, M; Wu-Wong, JR | 1 |
| Bajo, A; Barbosa, F; Borràs, M; Fontán, MP; González, T; Ramos, R; Sánchez, E | 1 |
| Coronel-Aguilar, D; Fernández-Viña, A; González-Díaz, I; Núñez-Moral, M; Peláez-Requejo, B; Quintana-Fernández, A; Rodríguez-Suárez, C; Sánchez-Álvarez, JE | 1 |
| Allende, N; Arias, M; García-Unzueta, MT; Izquierdo-Ortiz, MJ; López-Hoyos, M; Martín-de Francisco, ÁL; Piñera-Haces, C; Quintela, E; Toyos, C | 1 |
| Ettenger, R; Jüppner, H; Pereira, RC; Salusky, IB; Tsai, E; Wesseling-Perry, K | 1 |
| Kohler, M; Leiber, F; Liesegang, A; Merbold, L; Willems, H | 1 |
| Albero-Molina, MD; Álvarez-Avellán, L; del Pozo-Fernández, C; López-Menchero-Martínez, R; Sánchez-Rodríguez, L | 1 |
| Álvarez, V; Bernis, C; Bomback, AS; Coronel, F; de Lorenzo, A; Moya, M; Salanova, L; Sánchez-Tomero, JA | 1 |
| Bansal, N; Budoff, MJ; Criqui, MH; de Boer, IH; Hoofnagle, AN; Ix, JH; Katz, R; Kestenbaum, B; Laughlin, GA; Li, D; Siscovick, DS; Tracy, R | 1 |
| Amdahl, M; Chen, N; Huang, Z; Jiang, G; Khan, S; Li, X; Lin, H; Liu, L; Qian, J; Wang, M; Xing, C; Yan, Y; Yu, X; Zuo, L | 1 |
| Fishbane, S; Hazzan, A; Kline, M; Moledina, D; Patel, C; Sakhiya, V; Schanler, M; Shirazian, S | 1 |
| Biggar, P; Graf, H; Ketteler, M; Klauser-Braun, R; Kovarik, J; Müller, HW; Seidinger, S; Veres, A | 1 |
| Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Sharma, A | 1 |
| Cazaña-Pérez, V; Domínguez-Pimentel, V; Donate-Correa, J; Martín-Núñez, E; Mora-Fernández, C; Muros-de-Fuentes, M; Navarro-González, JF | 1 |
| Carpenter, TO; Cheng, D; Ellis, BK; Gundberg, CM; Insogna, KL; Olear, EA; Simpson, CA; Zhang, JH | 1 |
| Acosta Martínez, Y; Borrego Utiel, FJ; Bravo Soto, JA; García Álvarez, T; González Carmelo, I; López Jiménez, V; Mazuecos Blanca, MA; Merino Pérez, MJ | 1 |
| Craig, JC; Hahn, D; Hodson, EM | 1 |
| Bover, J; Egido, J; Fernández-Giráldez, E; Martínez-Castelao, A; Praga, M; Solozábal, C; Torregrosa, JV | 1 |
| Kalantar-Zadeh, K; Kumar, J; Pahl, M; Schomberg, J; Streja, E; Tran, NT | 1 |
| Fujii, H; Goto, S; Kono, K; Nakai, K; Nishi, S; Yonekura, Y | 1 |
| Aguirre Arango, JV; Restrepo Valencia, CA | 1 |
| Ariceta, G; Dell, KM; Dufek, MB; Eldred, A; Greenbaum, LA; Hoppe, B; Lee, HJ; Lerner, G; Linde, P; Warady, BA; Webb, NJA | 1 |
| Akdag, Y; Ersoy, FF; Hoser, H; Kendir, C; Koc, H | 1 |
| Al-Makki, A; Frost, K; Overholser, B; Shepler, B; Yun, SA | 1 |
| Geng, X; Shi, E; Song, Y; Wang, S | 1 |
19 review(s) available for phosphorus and vitamin d 2
| Article | Year |
|---|---|
Vitamin D.
Topics: Bone and Bones; Calcium; Chemistry; Cholecalciferol; Ergocalciferols; History, 18th Century; History, 19th Century; History, 20th Century; Intestinal Mucosa; Kidney; Muscles; Parathyroid Hormone; Phosphorus; Prolactin; Rickets; Vitamin D | 1977 |
Vitamin D as a prohormone.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Androgens; Animals; Bone and Bones; Calcium; Carrier Proteins; Cholecalciferol; Cytochrome P-450 Enzyme System; Ergocalciferols; Estrogens; Female; Ferredoxins; Humans; Hydroxycholecalciferols; Intestine, Small; Kidney; Male; Osteoporosis; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Vitamin D; Vitamin D Deficiency | 1977 |
Vitamin D metabolism and function.
Topics: Animals; Calcium; Cholecalciferol; Dihydroxycholecalciferols; Ergocalciferols; Gonadal Steroid Hormones; Humans; Hydroxycholecalciferols; Intestinal Absorption; Kidney; Liver; Parathyroid Hormone; Phosphorus; Vitamin D | 1979 |
Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II).
Topics: 24,25-Dihydroxyvitamin D 3; Administration, Oral; Age Factors; Alopecia; Bone and Bones; Calcitriol; Calcium; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Hypophosphatemia, Familial; Male; Minerals; Pedigree; Phosphorus; Tooth Abnormalities | 1986 |
Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
Topics: Animals; Biological Transport; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Intestinal Absorption; Intestines; Kidney; Liver; Osteomalacia; Osteoporosis; Phosphorus; Prednisolone; Rats; Rickets; Skin; Vitamin D | 1985 |
Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
Topics: Aluminum; Bone Regeneration; Calcium; Calcium Carbonate; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hydroxycholecalciferols; Intestinal Absorption; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Glands; Phosphorus; Secretory Rate; Vitamin D | 1973 |
Rickets in developing countries.
Topics: Adult; Animals; Calcium Metabolism Disorders; Child; Child, Preschool; Developing Countries; Ergocalciferols; Ergosterol; Fish Oils; Humans; Infant; Osteomalacia; Phosphorus; Rickets; Sunlight; Vitamin D Deficiency | 1972 |
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
Topics: Administration, Oral; Clinical Trials as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1998 |
Strategies to minimize bone disease in renal failure.
Topics: Animals; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Humans; Hyperparathyroidism; Osteoporosis; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency; Vitamin D | 2001 |
Vitamin D analogs for the treatment of secondary hyperparathyroidism.
Topics: Animals; Calcium; Ergocalciferols; Humans; Hyperparathyroidism; Phosphorus; Rats; Renal Insufficiency; Vitamin D | 2002 |
[New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics].
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium; Cinacalcet; Diphosphonates; Drug Therapy, Combination; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Retrospective Studies; Teriparatide; Transforming Growth Factor beta; Vitamin D | 2005 |
[News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].
Topics: Calcium; Chelation Therapy; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Phosphorus; Renal Dialysis | 2005 |
Bone and mineral disorders in pre-dialysis CKD.
Topics: Bone Density Conservation Agents; Chronic Disease; Comorbidity; Disease Progression; Ergocalciferols; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2008 |
Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U".
Topics: Calcium; Cinacalcet; Clinical Trials as Topic; Comorbidity; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Treatment Outcome; Vitamins | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease.
Topics: Cardiovascular Diseases; Ergocalciferols; Humans; Hyperparathyroidism; Hypocalcemia; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D | 2014 |
Interventions for metabolic bone disease in children with chronic kidney disease.
Topics: Aluminum Hydroxide; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Calcium Carbonate; Child; Chronic Disease; Ergocalciferols; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Sevelamer; Vitamin D | 2015 |
The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism.
Topics: Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Minerals; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2016 |
A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials.
Topics: Calcium; Disease-Free Survival; Ergocalciferols; Female; Humans; Male; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Receptors, Calcitriol; Renal Dialysis; Survival Rate | 2020 |
34 trial(s) available for phosphorus and vitamin d 2
| Article | Year |
|---|---|
[The idiopathic tetany syndrome in general practice (author's transl)].
Topics: Adolescent; Adult; Ascorbic Acid; Calcium; Child; Clinical Trials as Topic; Drug Combinations; Ergocalciferols; Female; Humans; Male; Middle Aged; Phosphorus; Placebos; Syndrome; Tetany | 1977 |
[Therapy of the postmenopausal osteoporosis using methyltestosterone plus ergocalciferol or methylandrostenedione].
Topics: Aged; Androstenediols; Blood Sedimentation; Calcium; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Methyltestosterone; Middle Aged; Osteoporosis; Phosphorus | 1976 |
[Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children].
Topics: Adolescent; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Clinical Trials as Topic; Ergocalciferols; Glomerulonephritis; Humans; Hydroxycholecalciferols; Phosphorus | 1989 |
Bone mineral content, serum vitamin D metabolite concentrations, and ultraviolet B light exposure in infants fed human milk with and without vitamin D2 supplements.
Topics: 25-Hydroxyvitamin D 2; Bone and Bones; Breast Feeding; Calcifediol; Calcitriol; Calcium; Double-Blind Method; Environmental Exposure; Ergocalciferols; Female; Growth; Humans; Infant, Newborn; Male; Minerals; Parathyroid Hormone; Phosphorus; Random Allocation; Ultraviolet Rays; Vitamin D Deficiency | 1989 |
Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Alkaline Phosphatase; Calcitriol; Calcium; Congenital Hypothyroidism; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hypercalcemia; Hypothyroidism; Infant, Newborn; Phosphorus; Thyroid Hormones; Thyrotropin; Thyroxine; Time Factors; Vitamin D | 1986 |
Hypercalcemia in mycobacterial infection.
Topics: Alkaline Phosphatase; Calcium; Calcium, Dietary; Clinical Trials as Topic; Depression, Chemical; Ergocalciferols; Humans; Hydrocortisone; Hypercalcemia; Phosphorus; Prednisone; Tuberculosis | 1972 |
Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
Topics: 25-Hydroxyvitamin D 2; Adolescent; Alkaline Phosphatase; Analysis of Variance; Bone Development; Calcitriol; Calcium; Child; Ergocalciferols; Female; Growth Hormone; Humans; Ilium; Insulin-Like Growth Factor I; Male; Osteocalcin; Parathyroid Hormone; Phosphorus; Prednisone; Prospective Studies; Recombinant Proteins; Reference Values | 1995 |
Vitamin D prophylaxis in children with a single dose of 150000 IU of vitamin D.
Topics: Alkaline Phosphatase; Argentina; Calcifediol; Calcium; Child; Child, Preschool; Creatinine; Ergocalciferols; Humans; Parathyroid Hormone; Phosphorus; Prospective Studies; Seasons; Vitamin D Deficiency | 1996 |
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
Topics: Administration, Oral; Clinical Trials as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1998 |
Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 1998 |
Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2.
Topics: Calcium; Double-Blind Method; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1998 |
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Double-Blind Method; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2000 |
A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Parathyroid Hormone; Phosphorus; Taste Disorders; Time Factors; Vomiting | 2001 |
Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
Topics: Calcitriol; Calcium; Ergocalciferols; Humans; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2001 |
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Calcium; Cohort Studies; Drug Resistance, Neoplasm; Ergocalciferols; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Neoplasm Proteins; Osteocalcin; Parathyroid Hormone; Phosphorus; Prodrugs; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome | 2002 |
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Topics: Aged; Calcium; Chronic Disease; Double-Blind Method; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2004 |
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Androgens; Antineoplastic Agents; Calcium; Ergocalciferols; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin D | 2005 |
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Capsules; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Vitamins | 2006 |
Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Topics: Adult; Aged; Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis | 2006 |
Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Topics: Adolescent; Adult; Bone Density Conservation Agents; Calcium; Child; Child, Preschool; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism; Infusions, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2007 |
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Placebos; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome | 2008 |
Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Bone Density Conservation Agents; Calcium; Creatinine; Double-Blind Method; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Renal Insufficiency, Chronic; Sample Size; Treatment Outcome; Vitamin D Deficiency | 2009 |
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients.
Topics: Adult; Calcitriol; Calcium; Cross-Over Studies; Ergocalciferols; Female; Humans; Intestines; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2010 |
Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Capsules; Ergocalciferols; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2012 |
No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial.
Topics: Adult; Aged; Calcium; Cross-Over Studies; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2011 |
Exposure-clinical response analysis of paricalcitol in patients with chronic kidney disease (stage 5) on hemodialysis or peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biological Availability; Calcium; Capsules; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2012 |
Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcifediol; Calcium; Drug Therapy, Combination; Ergocalciferols; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2012 |
Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis.
Topics: Aged; Biomarkers; Bone Density Conservation Agents; Calcifediol; Cardiovascular Diseases; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Risk Factors; Vitamin D | 2013 |
Oral paricalcitol as antiproteinuric agent in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Calcium; Chronic Disease; Creatinine; Ergocalciferols; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Treatment Outcome; Vitamin D | 2013 |
Efficacy and initial dose determination of paricalcitol for treatment of secondary hyperparathyroidism in Chinese subjects.
Topics: Adult; Aged; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Single-Blind Method | 2014 |
Longitudinal predictors of uremic pruritus.
Topics: Aged; Aged, 80 and over; Calcium; Double-Blind Method; Ergocalciferols; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Placebos; Pruritus; Renal Dialysis; Uremia | 2013 |
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Ergocalciferols; Female; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Child; Double-Blind Method; Ergocalciferols; Familial Hypophosphatemic Rickets; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Placebos; Prospective Studies; Treatment Outcome; Vitamin D; Young Adult | 2014 |
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.
Topics: Adolescent; Bone Density Conservation Agents; Calcium; Child; Double-Blind Method; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2017 |
171 other study(ies) available for phosphorus and vitamin d 2
| Article | Year |
|---|---|
Vitamin-D deficiency rickets in Jamaican children.
Topics: Alkaline Phosphatase; Black or African American; Breast Feeding; Calcium; Child; Child, Preschool; Diet; Ergocalciferols; Female; Growth; Humans; Hypophosphatemia, Familial; Infant; Jamaica; Male; Phosphorus; Rickets; Sunlight | 1976 |
Metabolism of vitamin D: current status.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Calcium; Cholecalciferol; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hydroxycholecalciferols; Kidney; Parathyroid Hormone; Phosphorus; Plants; Skin; Stereoisomerism; Steroid Hydroxylases; Structure-Activity Relationship; Vitamin D; Vitamin D Deficiency | 1976 |
Components of 25-hydroxyvitamin D in serum of young children in upper midwestern United States.
Topics: Alkaline Phosphatase; Calcium; Child; Child, Preschool; Cholecalciferol; Ergocalciferols; Humans; Hydroxycholecalciferols; Infant; Phosphorus; Seasons; United States; Vitamins | 1977 |
Parathyroid hormone and calcitonin levels in vitamin D deficient rickets.
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Cyclic AMP; Ergocalciferols; Female; Humans; Hydroxyproline; Infant; Italy; Male; Parathyroid Hormone; Phosphorus; Rickets | 1979 |
Assay for vitamin D2 and vitamin D3 in plasma of dairy cows: changes after massive dosing of vitamin D3.
Topics: Animals; Calcium; Cattle; Cholecalciferol; Chromatography, High Pressure Liquid; Colorimetry; Ergocalciferols; Female; Hypercalcemia; Injections, Intramuscular; Lipids; Phosphorus; Time Factors | 1979 |
A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D.
Topics: Absorption; Adolescent; Adult; Alkaline Phosphatase; Bone and Bones; Calcifediol; Calcitriol; Calcium; Cyclic AMP; Ergocalciferols; Female; Humans; Hypophosphatemia, Familial; Male; Phosphorus; Radiography; Syndrome | 1978 |
Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
Topics: Adult; Anticonvulsants; Bone and Bones; Bone Resorption; Calcium; Epilepsy; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphorus; Time Factors | 1977 |
Calcium and phosphorus metabolism in nephrotic syndrome.
Topics: Adolescent; Adult; Bone and Bones; Calcium; Ergocalciferols; Female; Humans; Intestinal Absorption; Malabsorption Syndromes; Male; Nephrotic Syndrome; Phosphorus | 1977 |
Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.
Topics: Adolescent; Alkaline Phosphatase; Calcium; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Hand; Humans; Hydroxycholecalciferols; Ilium; Phosphorus; Radiography; Renal Dialysis | 1977 |
Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis.
Topics: Adult; Aged; Bone and Bones; Calcium; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hydroxylation; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 1978 |
[Effect of an altered Ca/P ration in the diet on levels of alkaline phosphatase levels in rat].
Topics: Alkaline Phosphatase; Animals; Calcium, Dietary; Darkness; Ergocalciferols; Intestinal Mucosa; Kidney; Light; Male; Phosphorus; Rats; Rickets | 1978 |
Effect of vitamin D on pregnant rabbits and their offspring.
Topics: Animals; Animals, Newborn; Aortic Diseases; Calcinosis; Calcium; Cholesterol; Dose-Response Relationship, Drug; Ergocalciferols; Female; Fetal Death; Hydroxycholecalciferols; Magnesium; Phosphorus; Pregnancy; Rabbits | 1979 |
[Calcium and phosphrous evaluation during cortisone treatment of nephrotic syndrome in relapse].
Topics: Calcium; Child; Child, Preschool; Cortisone; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Intestinal Absorption; Magnesium; Male; Nephrotic Syndrome; Phosphorus | 1979 |
Intestinal absorption of calcium and phosphorus: Experiments on interaction between vitamin D and adrenocortical hormone.
Topics: Calcium; Child; Child, Preschool; Depression, Chemical; Ergocalciferols; Female; Humans; Intestinal Absorption; Male; Phosphorus; Prednisolone; Rickets; Stimulation, Chemical | 1975 |
The effect of fluoride alone or fluoride followed by calcium and vitamin D on disuse osteoporosis of the rat tail vertebrae.
Topics: Animals; Bone and Bones; Calcium; Drug Therapy, Combination; Ergocalciferols; Fluorides; Immobilization; Male; Osteoporosis; Phosphorus; Rats; Stress, Mechanical; Tail | 1975 |
1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
Topics: Adult; Alkaline Phosphatase; Bone Diseases; Calcium; Creatine; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypocalcemia; Middle Aged; Parathyroid Hormone; Phosphorus; Pseudohypoparathyroidism | 1976 |
Rickets in Nigerian children--response to vitamin D.
Topics: Alkaline Phosphatase; Calcium; Child; Child, Preschool; Ergocalciferols; Female; Gluconates; Humans; Infant; Male; Nigeria; Phosphorus; Rickets | 1975 |
Vitamin D toxicity after dieting in hypoparathyroidism.
Topics: Calcium; Child; Diet; Dihydrotachysterol; Ergocalciferols; Humans; Hypercalcemia; Hypocalcemia; Hypoparathyroidism; Magnesium; Male; Phosphorus; Vitamin D | 1976 |
Disturbances of mineral and bone metabolism following gastric antrectomy in the rat.
Topics: Animals; Bone and Bones; Bone Density; Calcitonin; Calcium; Cyclic AMP; Ergocalciferols; Femur; Gastrectomy; Gastrins; Intestinal Absorption; Magnesium; Male; Osteocalcin; Parathyroid Hormone; Phosphorus; Pyloric Antrum; Rats; Rats, Sprague-Dawley | 1992 |
[Bone mineralization in adult spasmophilia].
Topics: Adolescent; Adult; Bone Density; Calcium; Ergocalciferols; Female; Humans; Magnesium; Male; Middle Aged; Osteomalacia; Osteoporosis; Phosphorus; Tetany | 1991 |
Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height.
Topics: Body Height; Child, Preschool; Cholecalciferol; Ergocalciferols; Female; Growth; Humans; Hypercalcemia; Hypophosphatemia, Familial; Male; Parathyroid Hormone; Parents; Phosphates; Phosphorus; Puberty; Retrospective Studies; Vitamin D | 1990 |
Parity and vitamin D metabolites.
Topics: Alkaline Phosphatase; Blood Proteins; Calcium; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Parity; Phosphorus; Pregnancy; Saudi Arabia; Vitamin D | 1987 |
Effects of ergocalciferol supplementation on the concentration of vitamin D and its metabolites in human milk.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Calcium; Chromatography, High Pressure Liquid; Ergocalciferols; Female; Food, Fortified; Humans; Milk, Human; Phosphorus; Pregnancy; Vitamin D | 1989 |
Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism.
Topics: 25-Hydroxyvitamin D 2; Absorption; Adolescent; Bone and Bones; Bone Diseases; Calcifediol; Calcitriol; Calcium; Child; Child, Preschool; Cholestasis, Intrahepatic; Chronic Disease; Ergocalciferols; Female; Humans; Infant; Male; Minerals; Phosphorus; Vitamin D; Vitamin D-Binding Protein; Vitamin E | 1989 |
Stability of vitamin D2, calcium, magnesium, and phosphorus in parenteral nutrition solution: effect of in-line filter.
Topics: Calcium; Drug Stability; Drug Storage; Ergocalciferols; Filtration; Magnesium; Nurseries, Hospital; Parenteral Nutrition; Phosphorus; Solutions; Time Factors | 1986 |
Relationship between bone GLA-protein (BGP) and calcidiol (25-hydroxycalciferol) in serum of breast-fed infants.
Topics: 25-Hydroxyvitamin D 2; Alkaline Phosphatase; Bone and Bones; Breast Feeding; Calcitriol; Calcium; Calcium-Binding Proteins; Ergocalciferols; Female; Humans; Infant, Newborn; Lactation; Osteocalcin; Phosphorus; Pregnancy | 1986 |
Intermittent high-dose vitamin D prophylaxis during infancy: effect on vitamin D metabolites, calcium, and phosphorus.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Age Factors; Calcifediol; Calcium; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Ergocalciferols; Female; Humans; Infant; Infant, Newborn; Male; Phosphorus; Rickets; Vitamin D | 1987 |
[Oksidevit in the combined prevention of rickets in premature children].
Topics: Calcitriol; Calcium; Drug Evaluation; Drug Therapy, Combination; Ergocalciferols; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Phosphorus; Rickets | 1987 |
Influence of keto acid (KA) treatment on renal osteodystrophy.
Topics: Amino Acids; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Proteins; Ergocalciferols; Food, Fortified; Humans; Hyperparathyroidism, Secondary; Keto Acids; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1987 |
Vitamin D metabolism and osteomalacia in cystic fibrosis.
Topics: Adult; Bone and Bones; Calcium; Cystic Fibrosis; Ergocalciferols; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Hypocalcemia; Liver; Liver Cirrhosis; Magnesium; Malabsorption Syndromes; Male; Osteomalacia; Parathyroid Hormone; Phosphorus; Serum Albumin; Vitamin D | 1985 |
Late infantile tetany and secondary hyperparathyroidism in infants fed humanized cow milk formula. Longitudinal follow-up.
Topics: 25-Hydroxyvitamin D 2; Animals; Breast Feeding; Calcitonin; Calcitriol; Calcium; Cattle; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Infant Food; Infant, Newborn; Longitudinal Studies; Magnesium; Milk; Parathyroid Hormone; Phosphorus; Tetany | 1985 |
Defective vitamin D metabolism in thalassemia major.
Topics: Adolescent; Adult; Calcitriol; Calcium; Chelating Agents; Child; Child, Preschool; Deferoxamine; Ergocalciferols; Female; Humans; Hydroxyproline; Iron; Liver; Male; Parathyroid Hormone; Phosphorus; Thalassemia; Vitamin D | 1985 |
Serial serum 25-hydroxyvitamin D and mineral homeostasis in very premature infants fed preterm human milk.
Topics: 25-Hydroxyvitamin D 2; Alkaline Phosphatase; Birth Weight; Body Weight; Calcium; Ergocalciferols; Homeostasis; Humans; Infant Food; Infant, Newborn; Infant, Premature; Magnesium; Milk, Human; Parathyroid Hormone; Phosphorus; Serum Albumin; Time Factors | 1985 |
The effects of sodium fluoride, calcium phosphate, and vitamin D2 for one to two years on calcium and phosphorus metabolism in postmenopausal women with spinal crush fracture osteoporosis.
Topics: Aged; Bone and Bones; Bone Resorption; Calcium; Calcium Phosphates; Ergocalciferols; Female; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis; Phosphorus; Sodium Fluoride; Spinal Injuries; Time Factors | 1985 |
Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics.
Topics: Aged; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcium; Cell Division; Ergocalciferols; Female; Humans; Middle Aged; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Phosphorus; Sodium Fluoride | 1985 |
Metabolism and plasma protein transport of vitamin D 3 in the baboon.
Topics: Alkaline Phosphatase; Alpha-Globulins; Animals; Biological Transport; Biopsy; Blood Proteins; Body Weight; Calcium; Carbon Isotopes; Centrifugation; Cholecalciferol; Chromatography, DEAE-Cellulose; Chromatography, Gel; Diet; Electrophoresis, Disc; Ergocalciferols; Haplorhini; Immunoelectrophoresis; Lipoproteins; Male; Methods; Nutritional Requirements; Phosphorus; Protein Binding; Ribs; Serum Albumin; Spectrum Analysis; Vitamin D; Vitamin D Deficiency | 1971 |
1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure.
Topics: Adult; Alkaline Phosphatase; Calcium; Chemical Phenomena; Chemistry; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Hydroxylation; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus | 1973 |
Spontaneous cure of vitamin-D deficiency in Asians during summer in Britain.
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcium; Child; Cholecalciferol; Diet; Diet, Vegetarian; Ergocalciferols; Female; Humans; Hypocalcemia; Male; Middle Aged; Osteomalacia; Phosphorus; Rickets; Seasons; United Kingdom; Vitamin D Deficiency; White People | 1974 |
[Acute neonatal hypocalcemia with cardiomegaly in 2 children from a mother with hyperparathyroidism].
Topics: Adenoma; Adult; Alkaline Phosphatase; Calcium; Cardiomegaly; Cardiomyopathies; Ergocalciferols; Female; Humans; Hyperparathyroidism; Hypocalcemia; Hypoparathyroidism; Infant, Newborn; Infant, Newborn, Diseases; Parathyroid Hormone; Parathyroid Neoplasms; Perfusion; Phosphorus; Pregnancy; Pregnancy Complications | 1973 |
Comparison of the hypercalcemic action of vitamins D2 and D3 in chicks and the effect on tetracycline fixation by bone.
Topics: Animals; Blood Chemical Analysis; Bone and Bones; Calcium; Cholecalciferol; Ergocalciferols; Hypercalcemia; Phosphorus; Poultry; Rickets; Tetracycline | 1965 |
Comparative effects of dihydrotachysterol-2 and dihydrotachysterol-3 in chicks.
Topics: Animals; Bone and Bones; Calcium; Calcium, Dietary; Cholecalciferol; Chromatography, Thin Layer; Dihydrotachysterol; Ergocalciferols; Intubation, Intratracheal; Male; Phosphorus; Poultry; Rickets | 1966 |
A comparison of vitamin D2 and D3 in New World primates. I. Production and regression of osteodystrophia fibrosa.
Topics: Alkaline Phosphatase; Animals; Calcium; Cholecalciferol; Diet; Ergocalciferols; Female; Male; Monkey Diseases; Osteitis Fibrosa Cystica; Phosphorus | 1967 |
Inhibitor o,p'-DDD and vitamin D and dihydrotachysterol function in the chick.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Chickens; Cholecalciferol; Dichlorodiphenyldichloroethane; Dihydrotachysterol; Ergocalciferols; Liver; Male; Phosphorus; Rickets; Tibia; Vitamin D | 1967 |
The effects of vitamin D2 and dietary phosphorus on oxidative enzymes in the epiphyseal cartilage of rachitic rats. A histochemical study.
Topics: Animals; Cartilage, Articular; Diet; Epiphyses; Ergocalciferols; Glucosephosphate Dehydrogenase; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Hexoses; Histocytochemistry; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Male; NAD; Oxidoreductases; Phosphorus; Rats; Rickets | 1968 |
Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
Topics: Adult; Alkaline Phosphatase; Body Height; Body Weight; Calcium; Child, Preschool; Cholecalciferol; Ergocalciferols; Female; Humans; Hydroxyproline; Hypophosphatemia, Familial; Male; Osteomalacia; Phosphates; Phosphorus; Radiography; Wrist | 1972 |
Osteodystrophy of dialysed patients treated with vitamin D.
Topics: Adult; Alkaline Phosphatase; Calcium; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Female; Humans; Kidney Failure, Chronic; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Vitamin D | 1973 |
Electroencephalographic criteria of hypocalcemia and hypercalcemia.
Topics: Blood Urea Nitrogen; Brain; Calcium; Electroencephalography; Ergocalciferols; Female; Humans; Hypercalcemia; Hypocalcemia; Hypoparathyroidism; Middle Aged; Phosphorus; Seizures; Thyroidectomy | 1972 |
The effect of calciferol, parathormone and calcitonin on the biochemical composition of kidney.
Topics: Animals; Calcitonin; Calcium; Citrates; Ergocalciferols; Kidney; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Inbred Strains | 1972 |
A case of adult-onset vitamin-D resistant osteomalacia with elevated plasma parathyroid hormone level.
Topics: Amino Acids; Calcium; Drug Resistance; Ergocalciferols; Ethylenediamines; Female; Glycine; Humans; Injections, Intravenous; Knee; Osteomalacia; Parathyroid Hormone; Pelvic Bones; Phosphorus; Radiography | 1972 |
Primary hypophosphatemic rickets in an elderly woman.
Topics: Aged; Alkaline Phosphatase; Calcium; Ergocalciferols; Female; Fractures, Spontaneous; Humans; Phosphorus; Phosphorus Metabolism Disorders; Rickets | 1973 |
Neonatal rickets in Asian immigrant population.
Topics: Adult; Alkaline Phosphatase; Calcium; Emigration and Immigration; Ergocalciferols; Ethnicity; Female; Humans; India; Infant, Newborn; Infant, Newborn, Diseases; Male; Pakistan; Phosphorus; Rickets; Scotland | 1973 |
Cutaneous manifestations in idiopathic hypoparathyroidism.
Topics: Calcium; Ergocalciferols; Gluconates; Humans; Hypoparathyroidism; Injections, Intramuscular; Male; Middle Aged; Phosphorus; Skin Manifestations | 1974 |
Treatment of osteoporosis with vitamin D.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcium; Ergocalciferols; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Middle Aged; Osteoporosis; Phosphorus | 1974 |
Experimental band keratopathy.
Topics: Animals; Calcinosis; Calciphylaxis; Calcium; Cornea; Edetic Acid; Ergocalciferols; Eye Diseases; Hypercalcemia; Phosphorus; Rabbits; Sulfonic Acids; Ultraviolet Rays; Uveitis; Vitamin D | 1969 |
Vitamin D.
Topics: Calcification, Physiologic; Calcium; Citrates; Ergocalciferols; Humans; Phosphorus; Vitamin D | 1967 |
Hypoparathyroidism and malabsorption.
Topics: Calcium; Cataract; Ergocalciferols; Female; Humans; Hypoparathyroidism; Intestinal Mucosa; Malabsorption Syndromes; Middle Aged; Phosphorus | 1967 |
Beta-carotene vs. retinyl acetate for the baby pig and the effect upon ergocalciferol requirement.
Topics: Animals; Animals, Newborn; Blood Chemical Analysis; Bone Development; Calcium; Carotenoids; Diet; Ergocalciferols; Female; Male; Phosphorus; Swine; Vitamin A; Vitamin D | 1967 |
[Effect of vitamin D on calcium and phosphorus content of albino rat bones depending on calcium and fat content of the diet].
Topics: Animals; Bone and Bones; Calcium; Calcium, Dietary; Dietary Fats; Ergocalciferols; Phosphorus; Rats; Rickets | 1968 |
Pseudohypoparathyroidism with raised plasma alkaline phosphatase.
Topics: Adolescent; Alkaline Phosphatase; Bone and Bones; Calcium; Ergocalciferols; Humans; Kidney; Male; Osteitis Fibrosa Cystica; Parathyroid Hormone; Phosphorus; Pseudohypoparathyroidism; Radiography | 1969 |
Role of vitamin D in plasma calcium regulation.
Topics: Animals; Bone and Bones; Calcium; Calcium Isotopes; Diet; Ergocalciferols; Homeostasis; Male; Methods; Phosphorus; Rats; Tibia; Vitamin D Deficiency | 1969 |
Effect of level of soybean protein and ergocalciferol on mineral utilization by the baby pig.
Topics: Alkaline Phosphatase; Animals; Animals, Newborn; Blood Proteins; Calcium; Dietary Proteins; Ergocalciferols; Femur; Glycine max; Magnesium; Phosphorus; Swine | 1969 |
[The dynamics of phosphorus-calcium shifts and roentgenologic changes in rickets in relation to exercise therapy and ultraviolet irradiation].
Topics: Calcium; Ergocalciferols; Exercise Therapy; Humans; Infant; Massage; Phosphorus; Radiography; Rickets; Ultraviolet Rays | 1967 |
[The influence of Videin-2 and Videin-3 in combination with a citric acid mixture on the content of citric acid and inorganic phosphorus in the blood of children with rickets].
Topics: Caseins; Child; Citrates; Citric Acid Cycle; Ergocalciferols; Humans; Phosphorus; Rickets | 1967 |
Influence of zinc and vitamin D on bone constituents of the rat.
Topics: Analysis of Variance; Animals; Bone and Bones; Bone Development; Calcification, Physiologic; Calcium; Ergocalciferols; Femur; Male; Phosphorus; Rats; Stimulation, Chemical; Vitamin D; Water; Zinc; Zinc Isotopes | 1969 |
[Hypervitaminosis D2 due to daily ingestion of hydro-alcoholic solution of 400 U.I. per drop. Recovery following calcium-free diet and corticotherapy].
Topics: Calcium, Dietary; Diet Therapy; Ergocalciferols; Glomerular Filtration Rate; Humans; Hypercalcemia; Infant; Kidney Concentrating Ability; Male; Mother-Child Relations; Phosphorus; Prednisone; Rickets | 1969 |
Concepts of therapy. Prevention and management of osteodystrophy in patients with long-term hemodialysis.
Topics: Aluminum; Bone Diseases; Calcification, Physiologic; Calcium; Diet; Ergocalciferols; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism; Osteomalacia; Phosphorus; Renal Dialysis; Thyroidectomy; Vitamin D | 1969 |
Measurement of theoretical renal phosphorus threshold in the investigation and treatment of osteomalacia.
Topics: Adolescent; Adult; Ergocalciferols; Glomerular Filtration Rate; Humans; Kidney; Osteomalacia; Phosphates; Phosphorus; Rickets | 1970 |
Osteomalacia with long-term anticonvulsant therapy in epilepsy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Biopsy; Calcium; Enzyme Induction; Epilepsy; Ergocalciferols; Female; Humans; Male; Middle Aged; Osteomalacia; Phenytoin; Phosphorus; Primidone; Vitamin D | 1970 |
The effect of vitamin D in rats maintained on diets with different mineral content but with the same calcium to phosphorus ratio of unity.
Topics: Animals; Body Weight; Bone Development; Calcium; Calcium, Dietary; Diet; Ergocalciferols; Female; Male; Organ Size; Phosphorus; Rats; Tooth; Vitamin D | 1970 |
Effect ofvitamin D on thyro-parathyroidectomized rats.
Topics: Animals; Bone and Bones; Calcium; Calcium Isotopes; Calcium, Dietary; Ergocalciferols; Injections, Subcutaneous; Male; Organ Size; Parathyroid Glands; Phosphorus; Rats; Thyroidectomy; Tibia | 1970 |
Effectof vitamin D and calcium on survival ofthe thyro-parthyroidectomized rat.
Topics: Animals; Body Weight; Calcium; Calcium, Dietary; Ergocalciferols; Parathyroid Glands; Phosphorus; Rats; Thyroid Gland; Thyroidectomy; Vitamin D Deficiency | 1970 |
Effect of vitamin D on bone calcium metabolism in vitro.
Topics: Animals; Bone and Bones; Calcium; Calcium Isotopes; Calcium, Dietary; Culture Media; Ergocalciferols; Hydrogen-Ion Concentration; In Vitro Techniques; Phosphorus; Rats; Vitamin D Deficiency | 1970 |
Serum parathyroid hormone in X-linked hypophosphatemia.
Topics: Calcium; Diet Therapy; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism; Hypophosphatemia, Familial; Kidney Tubules; Male; Parathyroid Hormone; Phosphates; Phosphorus; Sex Factors | 1971 |
Calcium free peritoneal dialysis. Treatment of vitamin D intoxication.
Topics: Adult; Biological Transport; Bone and Bones; Calcium; Cell Membrane Permeability; Diabetic Retinopathy; Ergocalciferols; Female; Heart Failure; Humans; Hypercalcemia; Peritoneal Dialysis; Peritoneum; Phosphorus; Solutions; Uremia | 1971 |
Comparison of dihydrotachysterol and calciferol.
Topics: Analysis of Variance; Animals; Body Weight; Bone Resorption; Calcium; Diet; Dihydrotachysterol; Ergocalciferols; Hypercalcemia; Intestinal Absorption; Kidney; Magnesium; Phosphorus; Rats; Rats, Inbred Strains; Stomach; Tibia; Time Factors | 1971 |
Effect of various vitamin D analogs on plasma calcium and phosphorus and intestinal calcium absorption in fed and unfed American eels, Anguilla rostrata.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Calcitriol; Calcium; Chlorpromazine; Cholecalciferol; Dehydrocholesterols; Dihydroxycholecalciferols; Eels; Ergocalciferols; Fasting; Food; Intestinal Absorption; Phosphorus | 1984 |
The current status of the vitamin D metabolites.
Topics: Animals; Bone Diseases, Metabolic; Calcium; Cholecalciferol; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hydroxycholecalciferols; Intestinal Absorption; Kidney; Phosphorus | 1981 |
Plasma levels of vitamin D metabolites in diphosphonate-treated rats.
Topics: 25-Hydroxyvitamin D 2; Animals; Calcitriol; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, Drug; Ergocalciferols; Etidronic Acid; Male; Phosphorus; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Vitamin D metabolism in idiopathic infantile hypercalcemia.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Calcitriol; Cyclic AMP; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hypercalcemia; Infant; Male; Phosphates; Phosphorus; Vitamin D | 1981 |
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Bone Resorption; Calcium; Child; Cyclic AMP; Dihydroxycholecalciferols; Ergocalciferols; Homeostasis; Humans; Immobilization; Parathyroid Hormone; Phosphorus | 1982 |
Effect of the maternal vitamin D status at parturition on the vitamin D status of the neonatal calf.
Topics: Animals; Animals, Newborn; Calcium; Cattle; Cholecalciferol; Ergocalciferols; Female; Hydroxyproline; Labor, Obstetric; Magnesium; Phosphorus; Pregnancy; Pregnancy, Animal; Vitamin D | 1982 |
Vitamin D3 toxicity in dairy cows.
Topics: 25-Hydroxyvitamin D 2; Animals; Calcifediol; Calcium; Cattle; Cattle Diseases; Cholecalciferol; Ergocalciferols; Female; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Injections, Intramuscular; Labor, Obstetric; Magnesium; Phosphorus; Pregnancy | 1982 |
Probenecid inhibits the secretion of nephrogenous adenosine 3',5'-monophosphate in normal man.
Topics: 25-Hydroxyvitamin D 2; Adult; Calcitriol; Calcium; Cyclic AMP; Ergocalciferols; Humans; Male; Parathyroid Hormone; Phosphorus; Probenecid; Reference Values | 1983 |
Plasma concentrations of vitamin D metabolites before and during treatment of vitamin D deficiency rickets in children.
Topics: 24,25-Dihydroxyvitamin D 3; Alkaline Phosphatase; Calcifediol; Calcitriol; Calcium; Child; Cyclic AMP; Dihydroxycholecalciferols; Ergocalciferols; Humans; Infant; Parathyroid Hormone; Phosphorus; Rickets | 1984 |
Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man.
Topics: 25-Hydroxyvitamin D 2; Adult; Binding, Competitive; Calcitriol; Calcium; Creatinine; Ergocalciferols; Female; Humans; Liver; Male; Phosphorus | 1984 |
Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism.
Topics: Adult; Aged; Calcifediol; Calcitriol; Calcium; Creatinine; Ergocalciferols; Female; Humans; Male; Middle Aged; Phosphorus; Tuberculosis, Pulmonary | 1984 |
Plasma concentrations of vitamin D metabolites in a case of rickets of prematurity.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Alkaline Phosphatase; Calcitriol; Calcium; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Milk, Human; Phosphorus; Rickets | 1983 |
Effect of age and dietary calcium on renal 25(OH)D metabolism, serum 1,25(OH)2D, and PTH.
Topics: 25-Hydroxyvitamin D 2; Aging; Animals; Calcium; Diet; Ergocalciferols; Hydroxycholecalciferols; Kidney; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Inbred F344 | 1984 |
Serum calcium regulating hormones in the perinatal period.
Topics: Adult; Calcitonin; Calcitriol; Calcium; Carrier Proteins; Ergocalciferols; Female; Fetal Blood; Humans; Infant, Newborn; Male; Parathyroid Hormone; Phosphorus; Pregnancy; Vitamin D; Vitamin D-Binding Protein | 1982 |
The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
Topics: Adolescent; Adult; Aged; Bone and Bones; Calcifediol; Calcitriol; Calcium; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hypophosphatemia, Familial; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphorus; Rickets; X Chromosome | 1982 |
Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
Topics: 25-Hydroxyvitamin D 2; Adult; Calcitriol; Calcium; Cushing Syndrome; Ergocalciferols; Female; Homeostasis; Humans; Male; Models, Biological; Parathyroid Hormone; Phosphorus; Vitamin D | 1982 |
Acute vitamin D2 (ergocalciferol) toxicosis in horses: case report and experimental studies.
Topics: Animals; Blood Vessels; Body Weight; Calcium; Diet; Endocardium; Ergocalciferols; Horse Diseases; Horses; Male; Phosphorus | 1982 |
Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Topics: Adolescent; Adult; Aged; Body Weight; Calcifediol; Calcitriol; Calcium; Dihydrotachysterol; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postoperative Complications; Pseudohypoparathyroidism; Vitamin D | 1982 |
[Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Aged; Calcium; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Male; Middle Aged; Phosphorus; Pseudohypoparathyroidism | 1982 |
Observations on the natural history of vitamin D deficiency amongst Asian immigrants.
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Aged; Alkaline Phosphatase; Asia; Body Height; Calcium; Child; Child, Preschool; Diet; England; Ergocalciferols; Female; Humans; Male; Middle Aged; Phosphorus; Sunlight; Time Factors; Vitamin D Deficiency | 1982 |
Vitamin D metabolism in hypophosphatemic rickets.
Topics: 24,25-Dihydroxyvitamin D 3; Adolescent; Adult; Aged; Alkaline Phosphatase; Calcifediol; Calcitriol; Child; Child, Preschool; Dihydroxycholecalciferols; Ergocalciferols; Female; Humans; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphates; Phosphorus; Rickets; Vitamin D | 1982 |
Decreased bone mineral status in lactating adolescent mothers.
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Alkaline Phosphatase; Bone and Bones; Calcium; Diet; Ergocalciferols; Female; Humans; Lactation; Minerals; Phosphorus; Pregnancy; Pregnancy in Adolescence | 1982 |
Plasma 25-hydroxyvitamin D and rickets in infants of extremely low birthweight.
Topics: 25-Hydroxyvitamin D 2; Alkaline Phosphatase; Calcium; Ergocalciferols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Phosphorus; Rickets | 1982 |
[Effect of traditional Chinese medicine (dai-saiko-to) on experimental calcinosis].
Topics: Animals; Calcinosis; Calcium; Drugs, Chinese Herbal; Ergocalciferols; Estradiol; Female; Myocardium; Phosphorus; Rats; Rats, Sprague-Dawley | 1994 |
Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Aspartate Aminotransferases; Calcifediol; Calcitriol; Calcium; Creatinine; Cross-Sectional Studies; Ergocalciferols; Exercise; Female; Humans; Length of Stay; Male; Middle Aged; New York City; Nursing Homes; Nutrition Surveys; Nutritional Requirements; Phosphorus; Seasons; Serum Albumin; Vitamin D Deficiency | 1993 |
Effect of vitamin K2 on experimental calcinosis induced by vitamin D2 in rat soft tissue.
Topics: Animals; Aorta; Calcinosis; Calcium; Ergocalciferols; Kidney; Male; Phosphorus; Rats; Rats, Sprague-Dawley; Vitamin K | 1996 |
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Topics: Animals; Calcium; Ergocalciferols; Female; Intestinal Mucosa; Intestines; Nephrectomy; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Uremia | 1997 |
Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake.
Topics: Animals; Body Weight; Calcium; Chickens; Ergocalciferols; Food Deprivation; Gastrins; Gene Expression Regulation; Omeprazole; Parathyroid Hormone; Phosphorus; Vitamin D | 1997 |
Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
Topics: Animals; Calcitriol; Calcium; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Ergocalciferols; Female; Hyperparathyroidism, Secondary; Intestine, Small; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Uremia | 1998 |
Comparative effects of vitamin K2 and vitamin E on experimental arteriosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Calcium; Diet, Atherogenic; Elastin; Ergocalciferols; Free Radical Scavengers; Male; Naphthoquinones; Phosphorus; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vitamin E; Vitamin K; Vitamin K 3 | 1999 |
Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Topics: Animals; Bone and Bones; Calcitriol; Calcium; Calcium Channel Agonists; Ergocalciferols; Female; Phosphorus; Rats; Rats, Sprague-Dawley | 1999 |
Vitamin D2 is not biologically active for Rora (Labeo rohita) as vitamin D3.
Topics: Animals; Biological Availability; Calcium; Cholecalciferol; Ergocalciferols; Fishes; Lipid Metabolism; Phosphorus; Proteins | 1999 |
1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Topics: Animals; Biotransformation; Bone and Bones; Bone Density; Calcinosis; Calcium; Creatinine; Ergocalciferols; Female; Hydroxycholecalciferols; Kidney Diseases; Lumbar Vertebrae; Organ Specificity; Osteocalcin; Osteoporosis; Ovariectomy; Phosphorus; Prodrugs; Rats; Rats, Inbred F344; Tibia; Urea; Weight Gain | 2001 |
Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.
Topics: Calcitriol; Calcium; Dietary Proteins; Drug Resistance; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Serum Albumin | 2001 |
Severe secondary hyperparathyroidism.
Topics: Aged; Calcium; Drug Monitoring; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Treatment Outcome | 2001 |
Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.
Topics: Animals; Calcium; Ergocalciferols; Female; Male; Parathyroidectomy; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2002 |
Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care.
Topics: Aged; Calciphylaxis; Calcium; Debridement; Epoxy Compounds; Ergocalciferols; Humans; Kidney Failure, Chronic; Leg Ulcer; Male; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Wound Healing | 2002 |
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.
Topics: Adult; Aged; Bone Resorption; Calcitriol; Calcium; Cross-Over Studies; Diet; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis | 2002 |
Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients.
Topics: Adult; Calcium; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis | 2003 |
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
Topics: Adult; Aged; Aged, 80 and over; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cohort Studies; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Survival Rate | 2003 |
The uptake of injected radioactive phosphorus in the skeleton of the growing white rat. II. The effect of calciferol on the rapid uptake of 32P by rachitic and control animals.
Topics: Animals; Bone and Bones; Ergocalciferols; Phosphorus; Phosphorus Radioisotopes; Rats; Rickets; Skeleton; Vitamin D | 1953 |
[Study of the clinical use of a preparation of calcium, phosphorus, glutamic acid and vitamin D2, with rectal administration].
Topics: Administration, Rectal; Calcium; Calcium, Dietary; Ergocalciferols; Fatigue; Glutamates; Glutamic Acid; Humans; Phosphorus; Vitamin D; Vitamins | 1954 |
[Relations between calcium and phosphorus metabolism, Kreb's cycle and vitamin D2].
Topics: Calcium; Citrates; Ergocalciferols; Humans; Phosphorus; Vitamin D; Vitamins; Water-Electrolyte Balance | 1955 |
Comparison of the effects of crystalline dihydrotachysterol, vitamin D2 and parathyroid extract on calcium and phosphorus metabolism in man.
Topics: Calcium; Calcium, Dietary; Dihydrotachysterol; Ergocalciferols; Humans; Male; Nitrogen; Parathyroid Hormone; Phosphorus | 1962 |
Pharmacological research on the mineral metabolism of the bone under repair: methods and results.
Topics: Adrenocorticotropic Hormone; Bone and Bones; Bone Transplantation; Ergocalciferols; Estradiol; Gluconates; Humans; Minerals; Phosphorus; Phosphorus, Dietary; Progesterone; Testosterone | 1962 |
PSEUDOHYPOPARATHYROIDISM WITH OSTEITIS FIBROSA CYSTICA AND IMPAIRED ABSORPTION OF CALCIUM.
Topics: Alkaline Phosphatase; Calcium; Calcium Metabolism Disorders; Calcium, Dietary; Ergocalciferols; Hypoparathyroidism; Inulin; Kidney Tubules; Osteitis Fibrosa Cystica; Parathyroid Hormone; Pharmacology; Phosphorus; Pseudohypoparathyroidism; Rats; Urine | 1963 |
[BEHAVIOR OF SERUM MAGNESIUM IN RICKETS].
Topics: Alkaline Phosphatase; Blood Chemical Analysis; Calcium; Ergocalciferols; Humans; Infant; Magnesium; Phosphorus; Rickets | 1963 |
[OUR EXPERIENCES WITH THE ANABOLIC HORMONE THERAPY IN RICKETS PATIENTS].
Topics: Alkaline Phosphatase; Anabolic Agents; Blood Chemical Analysis; Blood Protein Electrophoresis; Calcium; Calcium, Dietary; Child; Ergocalciferols; Humans; Infant; Nandrolone; Phosphorus; Phosphorus, Dietary; Rickets; Serum Albumin; Steroids; Vitamin A | 1964 |
ON THE ABNORMAL CALCIUM ABSORPTION IN SARCOIDOSIS. EVIDENCE FOR INCREASED SENSITIVITY TO VITAMIN D.
Topics: Absorption; Alkaline Phosphatase; Ammonium Chloride; Biomedical Research; Blood Chemical Analysis; Calcium; Calcium Metabolism Disorders; Calcium, Dietary; Diet; Ergocalciferols; Feces; Nitrogen; Pharmacology; Phosphorus; Prednisone; Sarcoidosis; Urine; Vitamin D | 1964 |
EFFECTS OF HYPERVITAMINOSIS A AND D ON SKELETAL METABOLISM.
Topics: Bone and Bones; Calcium; Calcium Isotopes; Carbohydrate Metabolism; Collagen; Ergocalciferols; Glycosaminoglycans; Hexosamines; Hydroxyproline; Hypervitaminosis A; Pathology; Phosphorus; Phosphorus Isotopes; Proteins; Rats; Research; Toxicology; Urine; Vitamin A | 1964 |
EFFECT OF VITAMINS D2 AND D3 ON SERUM CALCIUM AND PHOSPHORUS IN RACHITIC CHICKS.
Topics: Animals; Blood; Calcium; Calcium, Dietary; Chickens; Cholecalciferol; Ergocalciferols; Microradiography; Nutritional Physiological Phenomena; Nutritional Sciences; Phosphorus; Phosphorus, Dietary; Poultry; Research; Rickets; Tibia; Vitamin D Deficiency; Vitamins | 1964 |
VITAMIN D2 REQUIREMENT OF THE BABY PIG.
Topics: Animals; Animals, Newborn; Blood; Calcium; Calcium, Dietary; Diet; Ergocalciferols; Magnesium; Magnesium Deficiency; Pathology; Phosphorus; Phosphorus, Dietary; Research; Rickets; Swine; Tetany; Vitamin D Deficiency | 1964 |
[EFFECT OF RADIOACTIVE STRONTIUM ON THE COURSE OF VITAMIN D-2 THERAPY OF EXPERIMENTAL RICKETS IN RATS].
Topics: Alkaline Phosphatase; Blood; Ergocalciferols; Pharmacology; Phosphorus; Phosphorus, Dietary; Radiation Injuries; Radiation Injuries, Experimental; Radioactivity; Rats; Research; Rickets; Strontium; Strontium Isotopes | 1964 |
EFFECTS OF INOSITOL-DEFICIENCY ON YEAST WITH PARTICULAR REFERENCE TO CHEMICAL COMPOSITION OF THE CELL AND OF THE CELL WALL.
Topics: Carbohydrate Metabolism; Cell Membrane; Cell Wall; Chromatography; Culture Media; Ergocalciferols; Inositol; Lipid Metabolism; Oleic Acid; Phosphorus; Proteins; Research; Saccharomyces; Saccharomyces cerevisiae; Yeasts | 1964 |
HYPOPHOSPHATEMIC RICKETS WITH RENAL HYPER-GLYCINURIA, RENAL GLUCOSURIA, AND GLYCYL-PROLINURIA. A SYNDROME WITH EVIDENCE FOR RENAL TUBULAR SECRETION OF PHOSPHORUS.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Chronic Kidney Disease-Mineral and Bone Disorder; Dipeptides; Ergocalciferols; Glycine; Glycosuria; Glycosuria, Renal; Humans; Hydroxyproline; Kidney Function Tests; Osteomalacia; Osteoporosis; Phosphates; Phosphorus; Phosphorus Metabolism Disorders; Radiography; Renal Aminoacidurias; Renal Tubular Transport, Inborn Errors; Rickets; Rickets, Hypophosphatemic; Urine | 1964 |
MINERAL BALANCE STUDIES WITH THE BABY PIG: EFFECTS OF DIETARY VITAMIN D2 LEVEL UPON CALCIUM, PHOSPHORUS AND MAGNESIUM BALANCE.
Topics: Animals; Calcium; Calcium, Dietary; Diet; Ergocalciferols; Feces; Magnesium; Metabolism; Minerals; Phosphorus; Phosphorus, Dietary; Research; Swine; Urine; Vitamin D Deficiency | 1965 |
COMPARISONS OF CASEIN AND SOY PROTEINS UPON MINEREAL BALANCE AND VITAMIN D2 REQUIREMENT OF THE BABY PIG.
Topics: Alkaline Phosphatase; Animals; Animals, Newborn; Blood; Bone Development; Calcium; Calcium, Dietary; Caseins; Dietary Proteins; Ergocalciferols; Feces; Femur; Glycine max; Growth; Magnesium; Minerals; Phosphorus; Phosphorus, Dietary; Plant Proteins; Research; Soybean Proteins; Swine; Urine; Vitamin D Deficiency | 1965 |
PRIMARY HYPERPARATHYROIDISM IN AN INFANT; REPORT OF A CASE.
Topics: Alkaline Phosphatase; Blood; Bone and Bones; Calcium; Calcium, Dietary; Diagnosis, Differential; Ergocalciferols; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Infant, Newborn, Diseases; Intellectual Disability; Pathology; Phosphorus; Radiography; Rickets | 1965 |
Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.
Topics: Calcitriol; Calcium; Control Groups; Ergocalciferols; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2003 |
Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.
Topics: Calcitriol; Calcium; Ergocalciferols; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2003 |
Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
Topics: Calcitriol; Calcium; Cohort Studies; Ergocalciferols; Humans; Injections; Parathyroid Hormone; Phosphorus; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Survival Analysis; Vitamin D | 2005 |
Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
Topics: Calcium; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Treatment Outcome | 2005 |
All-trans retinoic acid antagonizes the action of calciferol and its active metabolite, 1,25-dihydroxycholecalciferol, in rats.
Topics: Animals; Calcitriol; Calcium; Diterpenes; Ergocalciferols; Male; Phosphorus; Rats; Rats, Sprague-Dawley; Retinyl Esters; Tretinoin; Vitamin A | 2005 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.
Topics: Aged; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Female; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Proportional Hazards Models; Renal Dialysis; Risk Factors; Survival Analysis; Time Factors | 2006 |
Mortality risk among hemodialysis patients receiving different vitamin D analogs.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Analysis; Vitamin D | 2006 |
Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.
Topics: Alkaline Phosphatase; Aniline Compounds; Animals; Aorta; Calcinosis; Calcitriol; Calcium; Cattle; Cells, Cultured; Drug Combinations; Ergocalciferols; Gene Expression; Glycerophosphates; Muscle, Smooth, Vascular; Oligonucleotide Array Sequence Analysis; Phenethylamines; Phosphorus; Propylamines; Receptors, Calcitriol; Receptors, Calcium-Sensing; Signal Transduction; Wnt Proteins | 2006 |
Differential effects of vitamin D analogs on vascular calcification.
Topics: Animals; Aorta; Blood Pressure; Bone Density Conservation Agents; Calcinosis; Calcitriol; Calcium; Cells, Cultured; Ergocalciferols; Gene Expression; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nephrectomy; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vitamin D | 2007 |
Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcitriol; Calcium; Cardiovascular System; Chronic Disease; Creatinine; Ergocalciferols; Fibrosis; Male; Nephrectomy; Parathyroid Hormone; Peptidyl-Dipeptidase A; Phosphorus; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin | 2007 |
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
Topics: Animals; Cell Nucleus; Cells, Cultured; Coronary Vessels; Cytosol; Down-Regulation; Ergocalciferols; Gene Expression Regulation; Humans; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Oligonucleotide Array Sequence Analysis; Osteopontin; Phosphorus; PPAR gamma; Receptors, Calcitriol; Repressor Proteins; Thrombomodulin; Tissue Distribution; Up-Regulation | 2007 |
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats.
Topics: Animals; Aorta; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Ergocalciferols; Hyperparathyroidism, Secondary; Male; Phosphorus; Rats; Rats, Wistar; Uremia | 2008 |
Vitamin D receptor activators can protect against vascular calcification.
Topics: Animals; Aorta; Aortic Diseases; Bone Density Conservation Agents; Bone Diseases, Endocrine; Calcinosis; Calcitriol; Calcium; Dietary Fats; Ergocalciferols; Female; Femur; Gene Expression; Kidney Failure, Chronic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoblasts; Phosphorus; Receptors, Calcitriol | 2008 |
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Topics: Animals; Aorta; Blood Flow Velocity; Calcinosis; Calcium; Ergocalciferols; Hyperparathyroidism, Secondary; Male; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Insufficiency, Chronic; Uremia; Vascular Resistance | 2008 |
Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Registries | 2009 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Topics: Administration, Oral; Aged; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; C-Reactive Protein; Calcitriol; Calcium; Chelating Agents; Cholecalciferol; Chronic Disease; Darbepoetin alfa; Dietary Supplements; Ergocalciferols; Erythropoietin; Female; Hematinics; Humans; Hypertrophy, Left Ventricular; Inflammation Mediators; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Parathyroid Hormone; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Serum Albumin; Sevelamer; Time Factors; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Vitamins | 2010 |
Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
Topics: Administration, Oral; Adult; Aged; Calcium; Dose-Response Relationship, Drug; Ergocalciferols; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Treatment Outcome; Vitamin D Deficiency; Vitamins | 2010 |
Comparative effects of doxercalciferol (1α-hydroxyvitamin D₂) versus calcitriol (1α,25-dihydroxyvitamin D₃) on the expression of transporters and enzymes in the rat in vivo.
Topics: Animals; Bile Acids and Salts; Body Weight; Bone Density Conservation Agents; Calcitriol; Calcium; Cytochrome P-450 Enzyme System; Ergocalciferols; Gene Expression Regulation; Male; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Vitamins | 2011 |
Paricalcitol for reduction of albuminuria in diabetes.
Topics: Albuminuria; Bone Density Conservation Agents; Diabetic Nephropathies; Ergocalciferols; Humans; Long-Term Care; Phosphorus; Prognosis; Randomized Controlled Trials as Topic | 2011 |
Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.
Topics: Aged; Biomarkers, Pharmacological; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Observation; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Sweden | 2011 |
The effect of vitamin D derivatives on vascular calcification associated with inflammation.
Topics: Animals; Aorta; Blood Pressure; Blotting, Western; Bone Density Conservation Agents; Calcinosis; Calcitriol; Calcium; Cells, Cultured; Cytokines; Ergocalciferols; Female; Humans; Inflammation; Lipopolysaccharides; Muscle, Smooth, Vascular; Nephrectomy; Phosphorus; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Uremia; Vascular Diseases | 2012 |
Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease.
Topics: Aged; Aged, 80 and over; Body Mass Index; Calcium; Chronic Disease; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Evaluation; Endpoint Determination; Ergocalciferols; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
Topics: Animals; Blood Urea Nitrogen; Calcium; Creatinine; Ergocalciferols; Male; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Time Factors; Uremia | 2013 |
Effectiveness of treatment with oral paricalcitol in patients on peritoneal dialysis: a Spanish multicenter study.
Topics: Administration, Oral; Adult; Aged; Calcium; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Retrospective Studies; Spain | 2013 |
Paricalcitol reduces proteinuria but does not modify peritoneal protein loss in patients on peritoneal dialysis.
Topics: Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneum; Phosphorus; Prospective Studies; Proteins; Proteinuria; Renal Insufficiency, Chronic | 2013 |
FGF23 and mineral metabolism in the early post-renal transplantation period.
Topics: Adolescent; Blotting, Western; Calcitriol; Calcium; Child; Creatinine; Ergocalciferols; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Minerals; Parathyroid Hormone; Phosphates; Phosphorus; Young Adult | 2013 |
Influence of altitude on vitamin D and bone metabolism of lactating sheep and goats.
Topics: Altitude; Animal Feed; Animals; Bone and Bones; Calcium; Dairying; Dehydrocholesterols; Ergocalciferols; Female; Goats; Guanine; Lactation; Milk; Motor Activity; Phosphorus; Sheep; Vitamin D | 2013 |
Compliance with objectives based on different guidelines (KDIGO/S.E.N.) and analysis of the individual variability of mineral metabolism in haemodialysis patients in the medium term.
Topics: Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Ergocalciferols; Female; Follow-Up Studies; Goals; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis; Phosphorus; Postoperative Complications; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies | 2013 |
Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D 2; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcium; Cohort Studies; Cross-Sectional Studies; Ergocalciferols; Estrogen Replacement Therapy; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Radiography; Vitamin D | 2013 |
Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients: a German-Austrian, single-arm, open-label, prospective, noninterventional, observational study.
Topics: Aged; Alkaline Phosphatase; Austria; Bone Density Conservation Agents; Calcimimetic Agents; Calcium; Cinacalcet; Ergocalciferols; Female; Germany; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Cinacalcet; Drug Substitution; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postoperative Complications; Retrospective Studies | 2015 |
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Alkaline Phosphatase; Calcitriol; Calcium; Disease Management; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Parenteral Nutrition; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2016 |
Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
Topics: Animals; Aorta; Biomarkers; Bone Density; Bone Diseases; Calcitriol; Calcium; Ergocalciferols; Fibroblast Growth Factors; Gene Expression Regulation; Glucuronidase; Kidney; Kidney Failure, Chronic; Klotho Proteins; Male; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Vitamin D | 2017 |
Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.
Topics: Adult; Aged; Altitude; Calcitriol; Calcium; Colombia; Cross-Sectional Studies; Ergocalciferols; Female; Humans; Hyperparathyroidism; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Sunlight; Vitamin D; Vitamin D Deficiency | 2016 |
Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study.
Topics: Bone Density Conservation Agents; Calcium; Drug Monitoring; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Turkey | 2019 |
Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Calcium; Cholecalciferol; Cohort Studies; Ergocalciferols; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Vitamin D; Young Adult | 2019 |